Approximately 980,000 tablets of a prescription medicine to treat high blood pressure have been ordered removed from pharmacy shelves, with a full recall to be completed by early August after being found to contain an insufficient amount of a key ingredient, the Food and Drug Administration (FDA) announced Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Typhoon, rain cause over NT$2.6 billion in agricultural losses in Taiwan
07/14/2025 10:33 PM - Society
Warmth in the dark: Anonymous man shows respect to Taipower workers
07/14/2025 10:28 PM - Sports
Taiwan billiards star Chang Jung-lin dies suddenly aged 40
07/14/2025 09:54 PM - Business
Taiwan's stabilization fund to continue stock market intervention
07/14/2025 09:18 PM - Politics
Urban resilience drills begin Tuesday
07/14/2025 09:08 PM